John Boris Recent News
Citi Sees EPS Growth For Teva Pharmaceutical Industries (TEVA)
Citi Says Mylan (MYL) Shares Are A Buy
Citi Sees Strong Upside At Watson Pharmaceuticals (WPI)
Citigroup Rates Teva Pharmaceutical Industries (TEVA) A Buy After Court Ruling
Drug Pipeline Targeting High Growth Markets May Boost Merck Prospects (MRK, C)